The data showing Pmel-1 antigen–specific T cell proliferation specifically in TDLNs of mice treated with CTX and anti-GITR support the hypothesis that CTX induces tumor death and release of the Pmel antigen for Pmel-1 T cell recognition. This evidence concerns the gene TNFRSF18 and neoplasm.